Structured exercise programs keep cancer in remission, lower recurrence risks, and extend survival. Despite mounting clinical trial evidence and guidelines from major medical societies, most health insurance plans do not cover exercise oncology, forcing patients to find rehabilitation through hospital pilots, philanthropy, or community programs.
Clinical Trials Prove Exercise Lowers Recurrence And Extends Survival
A major randomized trial focused on colon cancer found that patients who participated in a supervised exercise program over three years experienced a lower risk of cancer return and were more likely to be alive eight years later. The three-year intervention cost about $3,000 per person and ultimately saved the health system money. Mounting clinical evidence shows that structured exercise routines do more than manage treatment side effects.
Across 11 trials encompassing 3,828 people, structured exercise was linked to a 23 percent lower risk of death, with the average participant aged about 54 years and trials following people for just over five years. Disease-free survival—measured as the time before cancer returns, a new tumor appears, or the patient dies—was 17 percent lower across seven trials with 5,077 participants.
Additional pooled analyses demonstrated an 18 percent drop in deaths from any cause across 13 trials, alongside a 26 percent reduction in deaths specifically from cancer across six trials. In breast cancer research, data from 124 inactive survivors in the I Can! trial within 5 years of diagnosis showed that a remotely delivered exercise program supported by coaching calls, emails, and Fitbit monitoring slowed the rate of biological aging over 12 months compared to a health and wellness education group. Blood samples were collected and cognitive assessments were conducted at baseline, 6 months, and 12 months.
Programs combining aerobic exercise with strength training were linked to a 25 percent lower risk, though strength training by itself showed no clear link to survival based on a single trial involving 129 people.
Insurance Coverage And Routine Care Lag Behind Clinical Evidence
Although the CHALLENGE trial demonstrated that structured exercise can reduce long-term recurrence risk and extend survival, translating clinical findings into daily medical practice remains difficult. Schmitz noted that the trial places exercise into a new evidentiary category where it actively saves lives. Jessica Scott, PhD, highlighted the question of how to consistently incorporate exercise into routine oncology care, noting that community oncology practices may lack the resources to offer CHALLENGE-like support. Michelle Ligibel noted that exercise topics can arise naturally at the beginning of care when patients worry about how a treatment plan may disrupt their life, pointing out that clinicians need to do more than just tell patients to get moving.
Insurance coverage for exercise oncology is rare. Most patients rely on hospital pilot programs, philanthropy, or community initiatives like the YMCA network, which offers a free exercise program for people with cancer. One exception is the University of Pittsburgh Medical Center, which plans to cover a tailored exercise program for breast cancer patients through its employee health plan, described by its architect as a giant experiment.
Professional organizations are adjusting standards to close the gap. The American College of Surgeons’ 2027 breast care standards call for accredited breast-care programs to perform functional screenings and recommend exercise or refer patients to physical therapy when appropriate.
Survivors Face A Daily Activity Gap Before Reaching Standard Goals
An analysis of national survey data covering 2018 to 2024 among more than 2.7 million U.S. adults showed that nearly 30 percent of adults with a cancer history reported doing no physical activity in the previous month, compared with roughly 24 percent of adults without a cancer history. Population-level surveys reveal that the primary divide in cancer survivorship occurs before patients ever reach the standard goal of 150 minutes of moderate activity per week.
However, among individuals who reported being physically active, activity rates matched those of the general population. In 2019, about half of physically active cancer survivors met the weekly 150-minute recommendation, a rate comparable to peers without a cancer history, and by 2023 those numbers had increased to roughly 60 percent in both groups.
Clinicians emphasize starting below the standard benchmark. Patients dealing with treatment history, current energy levels, and bodily recovery do not need to jump straight to 150 minutes. To view programs or enroll in community support, patients can check local offerings through the YMCA network.
